Want access to unlimited case records and advanced research tools? Create your free CasePortal account now. No credit card required to register.
Try CasePortal for FreeJ. Martinez Olguin grants a motion to toss all securities claims against Revance Therapeutic from stockholders who say the company misled them on how likely a proposed frown-lines drug was to get FDA approval. There is no proof that any of the alleged misrepresentations from the company were made with the intent to trick investors or are legally actionable in any way, even if they were "overly optimistic" about the drug's future.
To read this case, start your 14-day free trial.
Request a free trial account to get access to more case data, documents, and features.
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.